171 related articles for article (PubMed ID: 17004091)
1. [Association of a positive family history with histopathology and clinical course in early-onset prostate cancer].
Herkommer K; Paiss T; Merz M; Gschwend JE; Kron M
Urologe A; 2006 Dec; 45(12):1532-9. PubMed ID: 17004091
[TBL] [Abstract][Full Text] [Related]
2. [Prospective evaluation of prostate cancer screening in men with a family history of the disease].
Paiss T; Herkommer K; Kahn D; Gschwend JE; Küfer R; Maier C; Vogel W; Högel J; Hautmann RE
Urologe A; 2006 Aug; 45(8):1002-5. PubMed ID: 16830128
[TBL] [Abstract][Full Text] [Related]
3. Effect of family history on outcomes in patients treated with definitive brachytherapy for clinically localized prostate cancer.
Peters CA; Stock RG; Blacksburg SR; Stone NN
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):24-9. PubMed ID: 18692325
[TBL] [Abstract][Full Text] [Related]
4. Association between the clinical presentation and epidemiological features of familial prostate cancer in patients selected for radical prostatectomy.
Paiss T; Herkommer K; Bock B; Heinz H; Vogel W; Kron M; Kuefer R; Hautmann RE; Gschwend JE
Eur Urol; 2003 Jun; 43(6):615-21. PubMed ID: 12767361
[TBL] [Abstract][Full Text] [Related]
5. [Familial versus sporadic prostate cancer in the German population. Clinical and pathological characteristics in patients after radical prostatectomy].
Paiss T; Bock B; Gschwend JE; Heinz H; Vogel W; Kron M; Hautmann RE; Herkommer K
Urologe A; 2003 Jul; 42(7):946-53. PubMed ID: 12898039
[TBL] [Abstract][Full Text] [Related]
6. Outcome after radical prostatectomy in young men with or without a family history of prostate cancer.
Rouprêt M; Fromont G; Bitker MO; Gattegno B; Vallancien G; Cussenot O
Urology; 2006 May; 67(5):1028-32. PubMed ID: 16698363
[TBL] [Abstract][Full Text] [Related]
7. The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited.
Cremers RG; Aben KK; van Oort IM; Sedelaar JP; Vasen HF; Vermeulen SH; Kiemeney LA
Prostate; 2016 Jul; 76(10):897-904. PubMed ID: 26989049
[TBL] [Abstract][Full Text] [Related]
8. [Is the prostate cancer screening behaviour of men with familial predisposition predictable?].
Paiss T; Kahn D; Küfer R; Maier C; Vogel W; Gschwend JE; Hautmann RE; Herkommer K
Urologe A; 2005 Apr; 44(4):387-92. PubMed ID: 15726312
[TBL] [Abstract][Full Text] [Related]
9. No Detrimental Effect of a Positive Family History on Long-Term Outcomes Following Radical Prostatectomy.
Brath JM; Grill S; Ankerst DP; Thompson IM; Gschwend JE; Herkommer K
J Urol; 2016 Feb; 195(2):343-8. PubMed ID: 26239337
[TBL] [Abstract][Full Text] [Related]
10. Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy.
Siddiqui SA; Sengupta S; Slezak JM; Bergstralh EJ; Zincke H; Blute ML
J Urol; 2006 Sep; 176(3):1118-21. PubMed ID: 16890705
[TBL] [Abstract][Full Text] [Related]
11. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
12. Clinical and histopathological characteristics of familial prostate cancer in Finland.
Pakkanen S; Kujala PM; Ha N; Matikainen MP; Schleutker J; Tammela TL
BJU Int; 2012 Feb; 109(4):557-63. PubMed ID: 21507186
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological features of hereditary prostate cancer.
Keetch DW; Humphrey PA; Smith DS; Stahl D; Catalona WJ
J Urol; 1996 Jun; 155(6):1841-3. PubMed ID: 8618269
[TBL] [Abstract][Full Text] [Related]
14. Familial prostate cancer cases before and after radical prostatectomy do not show any aggressiveness compared with sporadic cases.
Azzouzi AR; Valeri A; Cormier L; Fournier G; Mangin P; Cussenot O
Urology; 2003 Jun; 61(6):1193-7. PubMed ID: 12809896
[TBL] [Abstract][Full Text] [Related]
15. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
16. Familial and hereditary prostate cancer by definition in an italian surgical series: clinical features and outcome.
Sacco E; Prayer-Galetti T; Pinto F; Ciaccia M; Fracalanza S; Betto G; Pagano F
Eur Urol; 2005 Jun; 47(6):761-8. PubMed ID: 15925070
[TBL] [Abstract][Full Text] [Related]
17. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
18. [Hereditary prostate cancer].
Nakata S; Ohtake N; Takei T; Yamanaka H
Nihon Rinsho; 2000 Jul; 58(7):1515-8. PubMed ID: 10921334
[TBL] [Abstract][Full Text] [Related]
19. Race as an independent predictor of outcome after treatment for localized prostate cancer.
Sohayda CJ; Kupelian PA; Altsman KA; Klein EA
J Urol; 1999 Oct; 162(4):1331-6. PubMed ID: 10492191
[TBL] [Abstract][Full Text] [Related]
20. [Familial prostate cancer and genetic predisposition].
Meissner VH; Jahnen M; Herkommer K
Urologe A; 2021 May; 60(5):567-575. PubMed ID: 33721089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
